Metagenomi Technologies News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Metagenomi technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Metagenomi Technologies Today - Breaking & Trending Today

Metagenomi Announces Closing of Initial Public Offering

EMERYVILLE, Calif., Feb. 13, 2024 (GLOBE NEWSWIRE) Metagenomi, Inc. (Nasdaq: MGX), a precision genetic medicines company committed to developing. ....

New York , United States , Exchange Commission , Wells Fargo Securities , Broadridge Financial Solutions , Metagenomi Inc , Capital Markets Corp , Equity Syndicate Department , Jp Morgan Securities , Equity Syndicate Prospectus Department , Nasdaq Global Select Market , Island Avenue , Markets Corp , Nasdaq Mgx , Metagenomi Technologies ,

Health News Roundup: US Senate Democrats grill pharma CEOs on drug prices; Illumina forecasts flat 2024 sales as sluggish demand drags on and more

Health News Roundup: US Senate Democrats grill pharma CEOs on drug prices; Illumina forecasts flat 2024 sales as sluggish demand drags on and more
devdiscourse.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from devdiscourse.com Daily Mail and Mail on Sunday newspapers.

New York , United States , Bristol Myers Squibb , Bill Anderson , Joaquin Duato , Robert Davis , Chris Boerner , Us Senate Democrats , Hikma Pharmaceuticals , Drug Administration , Novo Nordisk , Senate Committee On Health , Senate Committee , Wall Street , New Jersey Based , Bayer Backed Metagenomi , Metagenomi Technologies , Bayer Healthcare ,

Moderna-backed Metagenomi cuts US IPO valuation target to $563 million

Genetic medicines company Metagenomi Technologies said on Thursday it is aiming for a valuation of $563 million in its US initial public offering (IPO. ....

Metagenomi Technologies , Bayer Healthcare , Genetic Medicines ,

Moderna-backed Metagenomi cuts U.S. IPO valuation target to $563-million

Genetic medicines company Metagenomi Technologies plans to raise about $93.8-million in U.S. initial public offering ....

Log Increate Free , Metagenomi Technologies , Bayer Healthcare , United States ,

Moderna-backed Metagenomi cuts US IPO valuation target to $563 mln

Genetic medicines company Metagenomi
Technologies said on Thursday it is aiming for a
valuation of $563 million in its U.S. initial public offering
, a number that is at the low end of its initial. ....

Savio Dsouza , Shubhendu Deshmukh , Metagenomi Technologies , Bayer Healthcare , Saviod Souza ,